BIOMAT Database Logo BIOMAT Database Logo

Pharmacokinetics of phenylbutazone in chronic liver disease. 1980

C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008107 Liver Diseases Pathological processes of the LIVER. Liver Dysfunction,Disease, Liver,Diseases, Liver,Dysfunction, Liver,Dysfunctions, Liver,Liver Disease,Liver Dysfunctions
D008297 Male Males
D010653 Phenylbutazone A butyl-diphenyl-pyrazolidinedione that has anti-inflammatory, antipyretic, and analgesic activities. It has been used in ANKYLOSING SPONDYLITIS; RHEUMATOID ARTHRITIS; and REACTIVE ARTHRITIS. Diphenylbutazone,Fenilbutazon,Butacote,Butadion,Butadione,Butapirazol,Butapyrazole,Butazolidin
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Pharmacokinetics of quinine in chronic liver disease.
November 1995, British journal of clinical pharmacology,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Pharmacokinetics of phenylbutazone in camels.
June 1997, American journal of veterinary research,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Clinical pharmacokinetics of phenylbutazone.
January 1978, Clinical pharmacokinetics,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Theophylline pharmacokinetics and liver function indexes in chronic liver disease.
January 1991, Respiration; international review of thoracic diseases,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Pharmacokinetics of isradipine in patients with chronic liver disease.
January 1990, European journal of clinical pharmacology,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Pharmacokinetics of trapidil in patients with chronic liver disease.
October 1996, Journal of clinical pharmacology,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
[Granulomatous liver disease induced by phenylbutazone].
December 1975, Ugeskrift for laeger,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Pharmacokinetics of phenylbutazone in beef steers.
June 2002, Journal of veterinary pharmacology and therapeutics,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
Pharmacokinetics of phenylbutazone in neonatal foals.
December 1993, American journal of veterinary research,
C Adithan, and C H Shashindran, and I S Gandhi, and D S Singh, and J Balachandar
[Phenylbutazone and liver function; behavior of liver function in relation to treatment with phenylbutazone in normal and in liver disease].
June 1955, Archivio "E. Maragliano" di patologia e clinica,
Copied contents to your clipboard!